Researchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alzheimer’s
(By Andrew Joseph for ST A T) When the genome-editing tool CRISPR is thought of as a potential medicine, the
Read More(By Andrew Joseph for ST A T) When the genome-editing tool CRISPR is thought of as a potential medicine, the
Read More(By Judith Graham for KFF Health News) Millions of people enter later life carrying an extra 10 to 15 pounds,
Read MoreThe FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read More(By Rylee Wilson for Becker’s Hospital Review ) Leqembi, the newly-approved drug that can slow the progression of Alzhemier’s disease,
Read More(By Rylee Wilson for Becker’s Hospital Review ) Nearly half of Medicare Advantage beneficiaries report having at least one health-related
Read More(By Arthur Allen for KFF Health News) This week the FDA is expected to approve what many scientists and doctors
Read More(By Bari Faye Dean for Becker’s Hospital Review ) Older adults with Alzheimer’s disease and related dementia are twice as
Read More(By Jon Hamilton for NPR) The first drug shown to slow down Alzheimer’s disease is likely to receive full approval
Read MoreBy Sara Boden, WESA on June 20, 2023 for Kaiser Family Foundation Angela Reynolds knew her mother’s memory was slipping,
Read More(By Sarah Boden for NPR) Sharon Gwinn had been married almost 30 years when she cleared out the savings and
Read More